Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors

Endocrinology

Volumn 137, Issue 12, 1996, Pages 5589-5596

  Nakamura, Junji ^a,b   Savinov, Alexei ^a   Lu, Qing ^a   Brodie, Angela ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; AROMATASE INHIBITOR; ESTRADIOL; ESTROGEN; FORMESTANE; HYDROXYPROPYLCELLULOSE; MESSENGER RNA; TUMOR EXTRACT; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; ESTROGEN SYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; IMMUNOCYTOCHEMISTRY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030472169     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.12.8940388     Document Type: Article

References (41)

1. Folkman J, Klagsburn M 1987 Angiogenic factors. Scionce 235:442-447
2. Folkman J 1995 Tumor angiogenesis. In: Mendelsohn J, Howley PM, Israel MA, Liotta LA (eds) The Molecular Basis of Cancer. W. B. Saunders, Philadelphia, pp 206-232.
3. Blood CH, Zetter BR 1990 Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032:89-118
4. Weidner N, Semple JP, Welch WR, Folkman J 1991 Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1-8
5. Horak HR, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL 1992 Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120-1129
6. Fox SB, Leek RD, Smith K, Holler J, Greenall M, Harris AL 1994 Tumor angiogenesis in node-negative breast carcinomas-relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 29:109-116
7. Mahadevan V, Hart IR 1990 Metastasis and angiogenesis. Acta Oncol 29:97-103
8. Klagsbrun M, D'Amore PA 1991 Regulators of angiogenesis. Annu Rev Physiol 53:217-239
9. Ferrara N, Henzel WJ 1989 Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858
10. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, Haymore BL, Leimgruber R, Feder J 1989 Human vascular permeability factor. Isolation from U937 cells. J Biol Chem 264:20017-20024
11. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR 1992 Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3:211-220
12. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J 1989 Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478
13. Plate KH, Breier G, Weich HA, Risau W 1992 Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359:845-848
14. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips H, Ferrara N 1993 Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841-844
15. Senge DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF 1983 Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985
16. Yen KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF 1993 Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53:2412-2418
17. Ferrara N, Houck L, Jakeman L, Leung DW 1492 Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32
18. Cullinan-Bove K, Koos R 1993 Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133:824-837
19. Brodie A, Schwarzel W, Shaikh A, Brodie H 1977 The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione on estrogen dependent processes in reproduction and breast cancer. Endocrinology 100:1684-1645
20. Brodie A, Hammond J, Ghosh M, Meyer K, Albrecht E 1989 Effect of treatment with aromatase inhibitor 4-hydroxyandrostenedione on the nonhuman primate menstrual cycle. Cancer Res 44:4780-4784
21. Cathala G, Savouret JF, Mendez B, West BL, Karin M, Martial JA, Baxter JD 1983 A method for isolation of intact, transnationally active ribonucleic acid. DNA 2:324-335
22. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thoman KA 1990 Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87:2628-2632
23. Rappolee DA, Wang A, Mark D, Werb Z 1985 Novel method for studying mRNA phenotypes in single or small numbers of cells. J Cell Biochem 34:1-11
24. Lowry OH, Rosebrough NJ, Ferr AL, Randall RJ 1951 Protein measurement with the Polin phenol reagent. J Biol Chem 193:265-275
25. Wing L-Y, Hammond J, Brodie A 1988 Differential responses of sex steroid target tissues of rats treated with 4-hydroxyandrostenedione. Endocrinology 122:2418-2427
26. Ziehe M, Gullino FM 1981 Angiogenesis and prediction of sarcoma formation by plastic. Cancer Res 41:5060-5063
27. Ziehe M, Gullino PM 1982 Angiogenesis and neoplastic progression m vitro. J Natl Cancer Inst 64:483-487
28. Folkman J, Watson K, Ingber D, Hanahan D 1989 Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61
29. Folkman J 1985 Tumor angiogenesis. Adv Cancer Res 43:175-203
30. Mahadevan V, Hart IR 1991 Tumor angiogenesis and metastasis. Eur J Cancer 27:679-680
31. Connolly DT 1991 Vascular permeability factor; a unique regulator of blood vessel function. J Cell Biochem 47:219-223
32. Colburn P, Buonassisi V 1978 Estrogen-binding sites in endothelial cell cultures. Science 201:817-819
33. Corvazier E, Dupuy E, Dosne AM, Maclouf J 1984 Minimal effect of estrogens on endothelial cell growth and production of prostacyclin. Thromb Res 34:303-310
34. Johannisson E 1986 Effects of oestradiol and progesterone on the synthesis of DNA and the anti-hemophilic factor VIII antigen in human endometrial endothelial cells in vitro: a pilot study. Hum Reprod 1:207-212
35. McGuire A An update on estrogen and progesterone receptors in prognosis for primary and advanced breast cancer. Hormones and Cancer 15:337-344
36. Kaidoh T, Yasugi T, Uehara Y 1991 The microvasculature of the 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumor. Virchows Arch Pathol Anat 418:111-117
37. 3H-thymidine autoradiography. Basic Appl Histochem 24:21-43
38. Beato M 1989 Gene regulation by steroid hormones. Cell 56:335-344
39. Gagliardi A, Collins DC 1993 Inhibition of angiogenesis by antiestrogens. Cancer Res 53:533-535
40. Brodie AMH 1993 Aromatase, its inhibitors and their use in breast cancer treatment. Pharmacol Ther 60: 501-515
41. Lu Q, Nakamura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G, Brodie A 1996 Expression of aromatase protein and mRNA in tumor epithelial cells and evidence tor functionally significant aromatization in human breast cancer. Endocrinology 137:3061-3068